| 摘要 |
<p>The present invention provides peptides having anti-tumour activity and the use of these peptides as therapeutic agents. These peptides have an amino acid sequence substantially corresponding to amino acids 43 to 68 or 132 to 150 of the figure or a part thereof. Preferably the peptides have an amino acid sequence substantially corresponding to amino acids 43 to 58, 54 to 68, 132 to 150, 73 to 94, 81 to 94 or 70 to 80 of the figure.</p> |
